Skip to main content
. 2019 Feb 27;6(4):e204–e216. doi: 10.1016/S2352-3026(19)30003-1

Figure 2.

Figure 2

5-year Kaplan-Meier estimates of (A) progression-free survival and (B) overall survival in patients with high and low minimal residual disease

High minimal residual disease defined as ≥10−4 cells. Low minimal residual disease defined as <10−4 cells.